Company / Interest Expense per Share
Phathom Pharmaceuticals, Inc. Interest Expense per Share History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$1.01
FY2023
5-year range
$0.18 / $1.01
FY2019-FY2023
Trend
+45.0%
vs FY2022
Sector context
#8 of 43
Health Care
What the data says
Phathom Pharmaceuticals, Inc.'s interest expense per share of $1.01 is higher than 81% of companies in the Health Care sector (FY2023). Interest Expense per Share has increased for 3 consecutive years, from $0.14 in FY2020 to $1.01 in FY2023.
Based on SEC 10-K filings.
1.01 in FY2023 with a 5-year CAGR of +242.5%. Top quartile in the Health Care sector.
Increased from $0.18 to $1.01 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +94.3%
- 5-Year CAGR
- +242.5%
- 10-Year CAGR
- -
Sector benchmark
-89.7% below sector average
Key checks
Key Insights
- Phathom Pharmaceuticals, Inc.'s interest expense per share has grown for 3 consecutive years.
- In FY2023, interest expense per share increased 45.0% year-over-year.
- Ranks #8 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $1.01 | +45.0% |
| FY2022 | $0.70 | +280.5% |
| FY2021 | $0.18 | +33.1% |
| FY2020 | $0.14 | -62.5% |
| FY2019 | $0.37 | +17006.2% |
| FY2018 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026